# Vericel Corp: Form 10-Q for the period ended Mar 31, 2020

- Company: [Vericel Corp](/companies/vcel.md) (CIK 887359)
- Form: 10-Q
- Filed: 2020-05-11
- Accepted by EDGAR: May 11, 2020, 16:36 ET
- Period: 2020-03-31
- Accession: 0001628280-20-007473
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/887359/000162828020007473/vcel03-31x202010q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/887359/000162828020007473/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-01-01 to 2020-03-31 | $26.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2020-01-01 to 2020-03-31 | $9.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-01-01 to 2020-03-31 | $16.8m | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-01-01 to 2020-03-31 | $3.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-01-01 to 2020-03-31 | $18.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-01-01 to 2020-03-31 | −$5.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-01-01 to 2020-03-31 | $2.0k | us-gaap:InterestExpense |
| Net income | 3 months, 2020-01-01 to 2020-03-31 | −$4.7m | us-gaap:NetIncomeLoss |
| Operating cash flow | 3 months, 2020-01-01 to 2020-03-31 | $4.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2020-01-01 to 2020-03-31 | $717.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2020-03-31 | $45.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-03-31 | $116.5m | us-gaap:AssetsCurrent |
| Total assets | at 2020-03-31 | $150.3m | us-gaap:Assets |
| Current liabilities | at 2020-03-31 | $18.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-03-31 | $39.8m | us-gaap:Liabilities |
| Shareholders' equity | at 2020-03-31 | $110.5m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/887359/000162828020007473/vcel03-31x202010q.htm

Filed May 11, 2020.
Source: SEC EDGAR, the filing index for accession 0001628280-20-007473. Last ingested by Listed: Nov 13, 2026, 17:29 ET. No prices; not investment advice.